$CORZ

DUCHENE TODD M sold $262K of CORZ

DUCHENE TODD M (See remarks) sold 10,000 shares of Core Scientific, Inc./tx (CORZ) at an average of $26.17 ($25.99–$27.95, $0.26M total) across 3 trades on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DUCHENE TODD M
Published Jul 1, 2026, 11:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 11:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CORZ
Neutral
high confidence
Mentioned
$CORZ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CORZNeutralLow
01

Why it matters

The only new information is the size, timing, and execution details of the officer’s sale under a pre-arranged 10b5-1 plan; no new guidance, contracts, or regulatory actions are mentioned.

02

Market read

Traders may monitor insider activity for sentiment, but this specific disclosure is unlikely to drive a fundamental repricing without additional catalysts.

03

What to watch

The filing does not disclose reasons for sale, and the transaction is spread across three trades at a range of prices, consistent with routine execution.

Relevance 3/10Novelty 4/10Timing: today’s SEC Form 4 filing (filed 2026-07-01)

Background

This is an SEC Form 4 insider transaction disclosure for Core Scientific, Inc. (CORZ).

Company-level read

Ticker impact

$CORZNeutralHigh confidence
Context

Core Scientific (CORZ) disclosed an insider open-market sale by officer DUCHENE TODD M of 10,000 shares for about $261.7K under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any reaction is likely short-lived.

Evidence & confidence

Form 4 shows a pre-arranged 10b5-1 sale with no new company-specific operational or financial information.

Market effects

Minimal; insider-sale disclosures rarely reset sector expectations without accompanying guidance, financing, or legal/regulatory developments.

None.

None.

Counterpoint

Insider selling can still be interpreted as risk management or diversification, but the presence of a 10b5-1 plan reduces the signal strength.

Key entities

  • Core Scientific, Inc.

    Subject of the Form 4 insider transaction disclosure (CORZ).

  • DUCHENE TODD M

    Officer who sold 10,000 shares in open-market transactions under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRWVMed

CoreWeave, AI landlord stocks sink to lowest levels in more than a year as the price of insuring CoreWeave's debt doubles

Neocloud stocks, including CoreWeave (CRWV), IREN, Core Scientific (CORZ), and Cipher Mining (CIFR), have fallen over 40% since July. CoreWeave's credit default swap costs have doubled, signaling increased default risk. Microsoft (MSFT) has gained nearly as much. Nebius (NBIS) is an exception, performing better due to lower debt. Elon Musk noted lenders are restricting funding for AI data center-dependent companies.

$BTC-USDMed

AI Pivot Fails to Slow Bitcoin Mining Competition as Hashrate Surges

Bitcoin's network hashrate hit a seven-month high of 1 zettahash per second, despite large miners shifting to AI. Mining difficulty rose 5.92% in October, with another 5.16% increase expected. Public miners' hashrate fell 23% while AI revenue rose 52% in Q2 2026, displacing about $1.5 billion in equipment. Companies like Core Scientific and IREN reduced Bitcoin production, while MARA and Riot absorbed displaced network share.

$APLDMed

Applied Digital Sinks 4% as Rotation Out of Debt-Funded AI Builders Extends; TeraWulf Dips 3%, Core Scientific Retreats 2%

Applied Digital (APLD) shares fell 4% to $19.59, extending a downturn in leveraged AI data center developers. TeraWulf (WULF) and Core Scientific (CORZ) also declined. JPMorgan cut APLD's bond rating to Neutral, citing debt concerns. APLD reported strong Q1 revenue growth but carries significant debt. Management maintains confidence in its balance sheet and funding plans.

$CORZHigh

KBW keeps Core Scientific at outperform, says AMD’s 1.9 GW reservation is overlooked

KBW reiterated its Outperform rating and $28 price target on Core Scientific (CORZ), citing overlooked 1.9 GW of AMD reservation capacity. The firm values existing leases at $15.54 per share, with a blended NOI/EV yield of 8.3%. KBW attended Core Scientific's investor day and noted AMD's option for additional capacity. CORZ closed at $15.43 on Tuesday, implying 81.5% upside to the target.